Phase I-II trial of intramuscularly administered bleomycin.
D001761:Bleomycin / Q000008:administration & dosage* / Q000627:therapeutic use / Q000633:toxicity; D002986:Clinical Trials as Topic; D006801:Humans; D007273:Injections, Intramuscular; D009369:Neoplasms / Q000188:drug therapy*; D013997:Time Factors
D001761:Bleomycin